Speakers

Jason Adams

Head of CDx Partnering

Roche Molecular Solutions

Steve Anderson

Chief Scientific Officer

Covance

Jessica Atkinson

Vice President BioPharma Buisness Development

Foundation Medicine

Irene Bacalocostantis

Senior Manager, Regulatory Affairs

Regeneron

Lourdes Barrera

Senior Director, Precision Medicine, Global Precision Medicine Strategy, Oncology Business Unit

Novartis

Darrell Borger

Associate Director, Translational Oncology, ODDU

Takeda

Tooba Cheema

Director, Translational Medicine & Biomarkers

Oncorus

Jeffrey Emch

Vice President, Global Companion Diagnostics Strategy, Oncology

GSK

Joseph Ferrara

Chief Executive Officer

Boston Healthcare

Erin Grath

Director, Therapeutic Lead, Diagnostics & Devices, Regulatory Affairs International

Merck Research Laboratories

Nina Green

Vice President and General Manager, Companion Diagnostics

Agilent Technologies

Jennifer Hamilton

Executive Director & Head, Precision Medicine

Regeneron

Jennifer Herring

Executive Director & Head, Cellular Therapy Clinical Research Scientists

Bristol Myers Squibb

Jason Hipp

Senior Director, Head of Pathology Data Science & Innovation, Translational Medicine

AstraZeneca

Darren Hodgson

Global Project Leader & Head of Strategy, Translational Medicine

AstraZeneca

Michael Kiebish

Chief Precision Medicine Officer & Vice President, Systems Medicine

BERG Health

Karina Kulangara

R&D Director, Companion Diagnostics (CDx)

Agilent Technologies

Sid Mathur

Regulatory Affairs Director, Companion Diagnostics

Merck & Co.

Robert McCormack

Independent

Jayanthi Menon

Senior Manager, Regulatory Affairs

Regeneron

Kristina McGuire

Senior Director

Regeneron

Elizabeth O’Day

CEO & Founder

Olaris Therapeutics

Maria Orr

Head, Precision Medicine, Biopharmaceuticals

AstraZeneca

Robert Pomponio

Global Scientific Advisor, Biomarkers & Clinical Bioanalysis TMED

Sanofi

Vasiliki Pelekanou

Clinical Translational Medical Lead & Oncology

Sanofi

Julie Ramage

Director, Precision Medicine Quality Initiatives & Partnerships

AstraZeneca

Mark Roberts

Senior Director, Diagnostics Development

Covance

Lauren Silvis

Senior Vice President, External Affairs

Tempus

Elizabeth Somers

Diagnostic Pathway Lead, AD Franchise

Eisai

Beth Trehu

Chief Medical Officer

Jounce Therapeutics

Xiaolei Xu

Director, Global Regulatory Affairs, Companion Diagnostics

Agilent Technologies

Roman Yelensky

Chief Technology Officer

Gritstone Oncology

John Shon

CTO

Serimmune

Daniel Simon

Senior Vice President, BioPharma Business Development

Guardant Health

Karen Howarth

Head of Cancer Genomics

Inivata

Shyam Kalavar

Senior Scientific Reviewer, Molecular Pathology and Cytology Branch, Division of Molecular Genetics and Pathology

U.S. Food and Drug Administration

Tom Li

Head of US Biopharma BD

Burning Rock Dx

Shirin Khambata Ford

Head of Precision Medicine, Clinical Biomarkers and Companion Diagnostics

Daiichi Sankyo

Jennifer Rose

VP Sales, Pharma Services

NeoGenomics Laboratories

Kelli Bramlett

Director of R&D

Thermo Fisher Scientific

Madhushtree Ghosh

Vice President, Strategic Alliances & Projects, BioPharma Services

NeoGenomics Laboratories, Inc.

Katherine Landschulz

Head of Cardiovascular / Metabolic Disease, Biomarker Solution Center

Covance

Kedar Hastak

Sr. Field Applications Scientist

Personalis

Dawn McHugh

Sr. Director, Strategic Business Development

Personalis

Matt Humphries

Scientific Lead, Tissue Hybridization & Digital Pathology, Precision Medicine Centre of Excellence

Queen's University Belfast

Courtney Nicholson

Senior Director, Business Development

Abcam

Dan Liu

Regulatory Affairs Manager

Burning Rock Dx (Video Contribution)

Gavin Gordon

Vice President, Clinical Market Development

Akoya Biosciences